These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 1981300)
21. The effects of antipsychotic drugs on GABAA receptor binding depend on period of drug treatment and binding site examined. Skilbeck KJ; O'Reilly JN; Johnston GA; Hinton T Schizophr Res; 2007 Feb; 90(1-3):76-80. PubMed ID: 17208412 [TBL] [Abstract][Full Text] [Related]
22. The pharmacology of the benzodiazepine site of the GABA-A receptor is dependent on the type of gamma-subunit present. McKernan RM; Wafford K; Quirk K; Hadingham KL; Harley EA; Ragan CI; Whiting PJ J Recept Signal Transduct Res; 1995; 15(1-4):173-83. PubMed ID: 8903939 [TBL] [Abstract][Full Text] [Related]
28. Functional characterization of the 1,5-benzodiazepine clobazam and its major active metabolite N-desmethylclobazam at human GABA(A) receptors expressed in Xenopus laevis oocytes. Hammer H; Ebert B; Jensen HS; Jensen AA PLoS One; 2015; 10(3):e0120239. PubMed ID: 25798598 [TBL] [Abstract][Full Text] [Related]
29. Allosteric uncoupling after chronic benzodiazepine exposure of recombinant gamma-aminobutyric acid(A) receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity. Primus RJ; Yu J; Xu J; Hartnett C; Meyyappan M; Kostas C; Ramabhadran TV; Gallager DW J Pharmacol Exp Ther; 1996 Mar; 276(3):882-90. PubMed ID: 8786565 [TBL] [Abstract][Full Text] [Related]
30. Bidirectional effects of beta-carbolines in behavioral pharmacology. Proceedings of a workshop from the Sixth European Winter Conference on Brain Research. Avoriaz, France, March 9-15, 1986. Brain Res Bull; 1987 Sep; 19(3):291-400. PubMed ID: 2824001 [No Abstract] [Full Text] [Related]
32. Pharmacological characterization of the homomeric and heteromeric UNC-49 GABA receptors in C. elegans. Bamber BA; Twyman RE; Jorgensen EM Br J Pharmacol; 2003 Mar; 138(5):883-93. PubMed ID: 12642390 [TBL] [Abstract][Full Text] [Related]
33. Effects of hippocampal injections of a novel ligand selective for the alpha 5 beta 2 gamma 2 subunits of the GABA/benzodiazepine receptor on Pavlovian conditioning. Bailey DJ; Tetzlaff JE; Cook JM; He X; Helmstetter FJ Neurobiol Learn Mem; 2002 Jul; 78(1):1-10. PubMed ID: 12071663 [TBL] [Abstract][Full Text] [Related]
34. Effect of benzodiazepines and pentobarbital on the GABA-induced depolarization in cultured astrocytes. Backus KH; Kettenmann H; Schachner M Glia; 1988; 1(2):132-40. PubMed ID: 2852170 [TBL] [Abstract][Full Text] [Related]
35. Allosteric ligands and their binding sites define γ-aminobutyric acid (GABA) type A receptor subtypes. Olsen RW Adv Pharmacol; 2015; 73():167-202. PubMed ID: 25637441 [TBL] [Abstract][Full Text] [Related]
36. Two imidazoquinoxaline ligands for the benzodiazepine site sharing a second low affinity site on rat GABA(A) receptors but with the opposite functionality. Im HK; Im WB; Pregenzer JF; Stratman NC; VonVoigtlander PF; Jacobsen EJ Br J Pharmacol; 1998 Apr; 123(8):1490-4. PubMed ID: 9605552 [TBL] [Abstract][Full Text] [Related]
37. Aspects of benzodiazepine receptor structure and function with relevance to drug tolerance and dependence. Schoch P; Moreau JL; Martin JR; Haefely WE Biochem Soc Symp; 1993; 59():121-34. PubMed ID: 7910739 [TBL] [Abstract][Full Text] [Related]
38. Alpha1- and alpha2-containing GABAA receptor modulation is not necessary for benzodiazepine-induced hyperphagia. Morris HV; Nilsson S; Dixon CI; Stephens DN; Clifton PG Appetite; 2009 Jun; 52(3):675-683. PubMed ID: 19501766 [TBL] [Abstract][Full Text] [Related]
39. The pharmacology of cyclopyrrolone derivatives acting at the GABAA/benzodiazepine receptor. Doble A; Canton T; Piot O; Zundel JL; Stutzmann JM; Cotrel C; Blanchard JC Adv Biochem Psychopharmacol; 1992; 47():407-18. PubMed ID: 1324585 [No Abstract] [Full Text] [Related]
40. Transmembrane topology of the gamma-aminobutyric acidA/benzodiazepine receptor: subcellular distribution and allosteric coupling determined in situ. Czajkowski C; Gibbs TT; Farb DH Mol Pharmacol; 1989 Jan; 35(1):75-84. PubMed ID: 2536471 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]